We are excited to bring the conference coverage/highlights from the highly anticipated “2023 Precision Oncology Summit” that is taking place this weekend in the vibrant city of San Francisco. This important event
Presented by: Chris Chen, MD, Director, Early Drug Development, Stanford Cancer Institute Covered by: Inas Abuali, MD, FACP Dr. Chris Chen, director of the Early Drug Development Program at Stanford Cancer Institute,
More
Presented by: Shaji Kumar, M.D., Mark and Judy. Mullins Professor of Hematological Malignancies. Chair, Myeloma and Amyloidosis Group, Mayo Clinic, Rochester, MN. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of Hematology
More
Presented by: Michael A. Spinner, MD, Clinical Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD CAR T-cell therapy in hematologic malignancies has more options than ever before,
More
Presented by: Julia Carnevale, MD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD “Solid tumors are the next big frontier for cell therapies,” describes Dr. Julia Carnevale,
More
Presented by: Greg Allen, MD/PhD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD Dr. Greg Allen, assistant professor at the University of California San Francisco, delves into
More
Presented by: Christina Lockwood, PhD, Professor, University of Washington; Medical Director of Clinical Diagnostics, Brotman Baty Institute for Precision Medicine Covered by: Hannah Abrams, MD “Precision Oncology 101” begins with understanding
More
We are excited to bring the conference coverage/highlights from the highly anticipated “2023 Precision Oncology Summit” that is taking place this weekend in the vibrant city of San Francisco. This important event
More